Cite

Trichomoniasis is a common sexually transmitted parasitic disease [1]. Its prevalence is usually higher than for other sexually transmitted diseases (STDs). Diagnosis of Trichomonas vaginalis infection is cumbersome, and the infection is often asymptomatic and underdiagnosed. Trichomoniasis is an STD that increases the risk of human immunodeficiency virus (HIV) infection [2]. Asymptomatic trichomoniasis is associated with pregnancy complications such as premature rupture of membranes or amniorrhexis, preterm labor, low birth weight, endometritis after cesarean section, and abortus. Furthermore, newborn girls may be infected during birth and their infection may remain silent [3]. Trichomoniasis was found to be related to infertility and cervical dysplasia [4]. T. vaginalis infection, though often asymptomatic, may also result in a broad spectrum of signs and symptoms, such as foul smelling vaginal discharge, pelvic pain, dyspareunia, and dysuria. Furthermore, T. vaginalis infection may cause infertility because of endometritis, salpingitis, and atypical pelvic inflammatory symptoms [5, 6].

There is no simple diagnostic method with adequate sensitivity and specificity for T. vaginalis infection [1]. Therefore, special diagnostic tests are needed to confirm the presence of T. vaginalis. Diagnosis is usually made via observing parasites in a wet mount preparation. Although this method is inexpensive and fast, sensitivity is not high and the parasite is detected in only 60% of culture positive samples. Novel diagnostic methods such as nucleic acid amplification are more sensitive than routine diagnostic methods, but more expensive and not generally available [7, 8].

The aim of this study was to compare the presence of T. vaginalis in infertile and fertile Turkish women and to investigate the association of T. vaginalis with infertility.

Materials and methods

The ethics committee of Zeynep Kamil Women’s and Children’s Hospital, approved the study (protocol number 30.09.2013/93) and written informed consent was obtained from all patient participants.

The study population comprised 51 participants applying to the gynecology outpatient clinic between March and August 2013. The participants were divided into 2 groups: an infertility group (n = 22) and control group (n = 29). Women in the control group had complaints other than infertility. Women having systemic disease, pregnancy, foul smelling vaginal discharge, and taking antibiotics were excluded from study. Routine gynecological examinations were performed after women were informed about the objectives of the examination and a signed consent form was obtained. Three samples were taken from the posterior fornix via sterile cotton swabs during a speculum examination. The first sample was mixed with 1 mL sterile saline and direct microscopy was performed. One drop from the mixture was put on a slide and examined using light microscopy at ×400 magnification. The second sample was examined using light microscopy after Giemsa staining. The third sample was cultured in tubes containing cysteine– peptone–liver–maltose medium (CPLM). The tubes were incubated at 37°C for 48 hours and examined.

In both groups, after 12 h fasting on the third day of the menstrual cycle, the hormone profile or the patient and complete blood counts were measured. Hormone profile included follicle stimulating hormone (FSH), luteinizing hormone (LH), and 17β-estradiol (E2). These hormones were measured using standard enzymatic methods with a fully automated random access chemiluminescence-enhanced enzyme immunoassay system (Roche Laboratory Systems, Mannheim, Germany).

The data obtained were analyzed using PASW Statistics for Windows, version 18.0 (SPSS Inc, Chicago, IL, USA). The relationship between categorical variables in groups was evaluated using a chi-square or Fisher’s exact test. The relationship between continuous variables in groups was evaluated using a Student t test. P < 0.05 is was considered significant.

Results

T. vaginalis testing was positive in 18% (n = 4) of women in the infertile group and T. vaginalis was not observed in the control group (Figure 1).

Figure 1

Incidence of Trichomonas vaginalis in infertile and control patient groups

There was a significant difference in prevalence of T. vaginalis between the groups (P = 0.03 (odds ratio: 2.6 (95% confidence interval 1.8 to 3.7))).

The mean age, hemoglobin, hematocrit, platelet counts, FSH, LH, and E2 levels of all participants are presented in Table 1. Reasons of infertility are shown in Table 2.

Relationship of continuous variables in between groups

Infertility

Control

P

Student t test, FSH = follicle-stimulating hormone, LH = luteinizing hormone

Age (years)

29.5 ± 4.63

32.7 ± 6.45

0.06

Hemoglobin (g/dL)

12.09 ± 1.50

12.45 ± 1.48

0.40

Hematocrit (%)

35.87 ± 4.67

37.20 ± 4.63

0.32

Platelets (×1000/mm3)

301.59 ± 136.34

242.51 ± 65.63

0.046

FSH (IU/L)

14.52 ± 17.41

10.18 ± 8.75

0.25

LH (IU/L)

7.64 ± 5.97

8.88 ± 7.88

0.54

Estradiol (pmol/L)

105.92 ± 175.92

89.35 ± 87.44

0.66

Causes of infertility in infertile group

Frequency

Percent

Unexplained

7

31

Female factor (tubal factor and low ovarian reserve)

8

36

Male factor

7

31

While three patients with T vaginalis had unexplained infertility, one patient infected with T vaginalis also had male factor infertility.

Discussion

Trichomonas vaginalis infection results from an anaerobic flagellated protozoan and may result in serious health consequences, but is readily treatable [9]. This infection has been related to vaginitis, endometritis, salpingitis, infertility, preterm labor, low birth weight, increased incidence of human papilloma and HIV infections, and cervical cancer [2, 10]. The incidence of infection is high in adolescent girls [5, 6, 11].

Diagnosis of trichomoniasis is made by observing parasite trophozoites using light microscopy, direct florescent antibody testing, latex agglutination, enzyme-linked immunosorbent assays, and molecular polymerase chain reaction techniques. Culture and staining techniques may be used in diagnosis of disease in samples taken from vaginal, urethral, prostatic secretions, and urine [12, 13]. Culture is considered to be the criterion standard for diagnosis of trichomoniasis with a sensitivity of 95% [12]. We performed microscopic examination, Giemsa staining, and CPLM culture on samples taken from the posterior fornix.

Prevalence of T. vaginalis was found to be 3.1%-8.7% in reproductive aged women in USA by nucleic acid amplification test [14, 15]. The prevalence may increase to 38% in drug using African-American women and 9%–30% in HIV positive women [16, 17]. The prevalence of T. vaginalis in Turkish women depends on the study population and diagnostic methods used. Akarsu et al. reported the prevalence of T. vaginalis infection among women working in brothels in Ankara at 4.9% (n = 246) where the diagnosis was by direct microscopy and culture [18]. Sonmez-Tamer et al. detected T. vaginalis in 5.4% of women with vaginal discharge by direct microscopy and 9.3% of these women by culture (n = 128) [19]. In a retrospective study, the presence of T. vaginalis was investigated in random infertile women with vaginal discharge and in asymptomatic infertile women 2 weeks before in vitro fertilization. Trichomonas vaginalis was detected in only 3% of women with vaginal discharge using a FDA-cleared nucleic acid probe test [10]. In the present study, we found the prevalence of T. vaginalis was 18% in infertile women by culture in those with vaginal discharge. Consistent with our study, El-Shazly et al. [20] showed significantly higher T. vaginalis in a group of infertile women compared with a control group (14.58% vs 2.5% respectively).

Increased levels of IgA, IgG, Th1 cytokines and reactive nitrogen intermediates were observed in rats having experimentally induced T. vaginalis [8, 21]. Antibodies against T. vaginalis were detected in circulation and vaginal mucosa of infected women [8, 22, 23]. T. vaginalis cysteine proteases including CP30 may induce apoptosis of vaginal epithelial cells and multiple mucosal immune cell types [8, 24]. These immunological changes may be a cause of infertility.

The prevalence of T. vaginalis infection increased in infertile women having tubal factor infertility and pelvic inflammatory disease [20, 25]. Interestingly, the prevalence of T. vaginalis infection was 25% in women with male factor infertility and 75% in women with unexplained infertility. T. vaginalis was not detected in women with tubal factor infertility in our study. These findings may be related to immunological changes because of infection or independently. Our study is limited because of its small sample size.

Conclusion

Asymptomatic infertile women should be examined for T. vaginalis infection. Further studies are needed to elucidate the pathophysiology of infertility in relation to T. vaginalis infection.

eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine